Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence of Brucella Antibodies in High-Risk Patients With Low Back Pain: A Case-Control Study

NCT07112677 is registered in ClinicalTrials.gov with Elham Ahmed Hassan as lead sponsor.

NCT NCT07112677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07112677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence of Brucella Antibodies in High-Risk Patients With Low Back Pain: A Case-Control Study
Lead sponsor
Elham Ahmed Hassan
Phase
Observational
Overall status
Completed
Start date
February 1, 2024
Completion date
February 28, 2025
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brucellosis, low back pain